Fisher & Paykel posts 43% profit rise, lifts dividend
Make us a preferred source
Make us a preferred source on Google
The news: Health equipment provider Fisher & Paykel reported a 43% rise in net profit for the 2025 financial year to NZD377.2 million ($348.1 million), boosted by growth in hospital consumables and masks for treating obstructive sleep apnea.
The numbers: Fisher & Paykel recorded total operating revenue of NZD2.02 billion, an increase of 16% from the prior financial year. The company's final dividend of 42.5 cents per share represents an increase of 2% year on year.
Fisher & Paykel said it expects operating revenue for the 2026 financial year to be between NZD2.15 billion and NZD2.25 billion, and net profit after tax to be between NZD390 million and NZD440 million.
The context: The group said it expects an overall improvement in gross margin in FY26. Its outlook includes an estimated 50-basis point impact of US tariffs on hospital products sourced from New Zealand, it noted.
What they said: "Our action in response to any trade policy developments will be driven by our longstanding approach, which is to mitigate cost increases from any source by identifying and implementing continuous improvements and efficiency gains across all of our business processes," said managing director and chief executive Lewis Gradon.
The sources: ASX, RBC Capital Markets research
